Skip to main content
AGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026
Hit enter to search or ESC to close
Close Search
search
Menu
Home
CDMO Services
Services &
Capabilities
Process Development
API Life Cycle Management
Quality Management
CDMO Supply Chain Management
Technologies & Facilities
About us
AGC Pharma Chemicals
Sustainability
AGC Group and AGC Life Science Company
Careers
Join Us
Why AGC Pharma Chemicals?
Contact us
search
緑内障治療薬原体「タフルプロスト」の製造販売承認取得
6th March 2026
• 緑内障治療薬原体「タフルプロスト」の製造販売承認取得
Close Menu
Home
CDMO Services
Services & Capabilities
Process Development
API Life Cycle Management
Quality Management
CDMO Supply Chain Management
Technologies & Facilities
About us
AGC Pharma Chemicals
Sustainability
AGC Group and AGC Life Science Company
Careers
Why AGC Pharma Chemicals?
Join Us
Contact us
